Karin de Winter-de Groot

PHD Candidate - Medical

Strategic program(s):

Contact

kwinter@umcutrecht.nl

Pure profile

Research groups

Cellular disease models

Research aim

To develop patient-derived cell models to understand the molecular mechanisms of disease, to identify and validate targets for treatment, and to develop drugs and precision medicine applications.

Go to group

Pediatric pulmonology

Research aim

We unravel biological, clinical and psychosocial aspects of lung diseases like Cystic Fibrosis, Primary Ciliary Dyskinesia and oncology to continuously improve diagnosis and treatment by implementing latest scientific insights into clinical care.

Go to group

Recent publications

All publications

Outcomes of SARS-CoV-2 infection post-solid organ transplantation in the cystic fibrosis population Julie Semenchuk, Yumi Naito, Susan C Charman, Siobhán B Carr, Jamie Duckers, Stephanie Y Cheng, Bruce C Marshall, Albert Faro, Alexander Elbert, Christopher H Goss, Pierre-Régis Burgel, Carla Colombo, Marco Salvatore, Nataliya Kashirskaya, Laura Kirwan, Peter G Middleton, Lutz Naehrlich, Maria Dolores Pastor-Vivero, Andreas Jung, Egil Bakkeheim, Anna Zolin, Annalisa Orenti, Domenique D Zomer-van Ommen, Marco Zampoli, Anne L Stephenson, , Harry Heijerman, Karin de Winter-de Groot
Journal of Cystic Fibrosis, 2026, vol. 25, p.670-677

The Promising Role of Intestinal Organoids in the Diagnostic Work-Up of Cystic Fibrosis Screen Positive Inconclusive Diagnosis/CFTR-Related Metabolic Syndrome (CFSPID/CRMS) Noelia Rodriguez Mier, Marlies Destoop, Sacha Spelier, Anabela Santo Ramalho, Jeffrey M Beekman, François Vermeulen, Marijke Proesmans, Karin M de Winter-de Groot
International Journal of Neonatal Screening, 2025, vol. 11

CFTR modulator therapy via carrier mother to treat meconium ileus in a F508del homozygous fetus M Destoop, C Brantner, E B Wilms, Shaj Tytgat, B Peels, R van der Graaf, T B Y Liem, K M de Winter-de Groot
Journal of Cystic Fibrosis, 2025, vol. 24, p.476-478

Introduction of Ivacaftor/Lumacaftor in Children With Cystic Fibrosis Homozygous for F508del in the Netherlands A. M. Zwitserloot, S. Z. Aziz, Y. Chen, M. A.G.E. Bannier, H. M. Janssens, P. F.J.M. Merkus, M. Nuijsink, S. W.J. Terheggen-Lagro, H. A.W.M. Tiddens, D. D. Zomer- van Ommen, J. M. Vonk, K. M. de Winter- de Groot, B. W.M. Willemse, G. H. Koppelman
Pediatric Pulmonology, 2025, vol. 60

Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis Julie Semenchuk, Yumi Naito, Susan C. Charman, Siobhán B. Carr, Stephanie Y. Cheng, Bruce C. Marshall, Albert Faro, Alexander Elbert, Hector H. Gutierrez, Christopher H. Goss, Bulent Karadag, Pierre Régis Burgel, Carla Colombo, Marco Salvatore, Rita Padoan, Géraldine Daneau, Satenik Harutyunyan, Nataliya Kashirskaya, Laura Kirwan, Peter G. Middleton, Rasa Ruseckaite, Isabelle de Monestrol, Lutz Naehrlich, Pedro Mondejar-Lopez, Andreas Jung, Jacqui van Rens, Egil Bakkeheim, Annalisa Orenti, Domenique Zomer-van Ommen, Luiz Vicente RF da Silva-Filho, Flavia Fonseca Fernandes, Marco Zampoli, Anne L. Stephenson, Irena Kasmi, Ouardia Drali, Sabine Burghart, Andrea Lakatos-Krepcik, Johannes Eder, Peter Jaksch, Katharina Kainz, Margit Kallinger, Alexander Leitner, Marta Mozdzen, Andreas Pfleger, Sabine Renner, Martin Stadlinger, Christina Thir, Emil Nuriyev, Harry Heijerman, Renske van der Meer, Karin de Winter-de Groot,
Journal of Cystic Fibrosis, 2024, vol. 23, p.815-822

Natural course of CPAM and pulmonary sequestration Karin M de Winter-de Groot
Pediatric Pulmonology, 2024, vol. 60, p.S64-S65

External positions

Voorzitter Sectie Kinderlongzieken van de NVK - Wetenschappelijke vakvereniging - Nederlands Vereniging voor Kindergeneeskunde